DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

RBC Capital Upgrades Chemed to Outperform, Raises Price Target to $535

RBC Capital analyst Frank Morgan upgrades Chemed (NYSE:CHE) from Sector Perform to Outperform and raises the price target from $448 to $535.

Benzinga · 03/11/2020 10:42

RBC Capital analyst Frank Morgan upgrades Chemed (NYSE:CHE) from Sector Perform to Outperform and raises the price target from $448 to $535.